drugset / Trial / NCT00567060
Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to explore in a more documented way the relative potential and efficacy of piracetam 9600 and 4800 mg daily.
Timeline
- Start
- 2000-05
- Primary completion
- 2004-01
- Completion
- 2004-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Piracetam | Small molecule | 4800 mg | — |
| Subject | Piracetam | Small molecule | 9600 mg | — |